Follow‐up post‐ HCV virological response to DAA in advanced chronic liver disease
Liver International · 2024
DOI: 10.1111/liv.16113 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Liver International, 2024. Verfasst von A Romano und 5 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Internal Medicine and Hepatology, Department of Medicine, University of Padova, Padova, Italy. Hauptthemen laut MEDLINE: Antiviral Agents, Sustained Virologic Response, Hepatitis C, Chronic, Disease Progression. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 112 Literaturangaben.
Abstract (Originalsprache)
Direct‐acting antivirals (DAA) achieve high virological response rates with minimal side effects for many patients. Despite their significant impact on the progression and epidemiology of hepatitis C virus (HCV) associated liver disease, the global annual incidence of chronic infections is expected to remain relatively constant, averaging 1.42 million new cases each year until 2030. Furthermore, by 2030, there will be a 14–17% increase in end‐stage liver disease outcomes such as liver‐related deaths, hepatocellular carcinoma (HCC), and decompensated cirrhosis in adults aged 18 years and over. Although reductions in liver decompensation, HCC occurrence, and mortality have been shown in patients with advanced liver disease who achieved sustained virological response (SVR) with DAA, these benefits may be less significant in those with decompensated liver cirrhosis. This review aims to summarise the impact of the virological response to DAA on liver disease progression and outcomes in patients with advanced chronic liver disease, which appears to be crucial for defining patient‐specific follow‐up.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Unit of Internal Medicine and Hepatology, Department of Medicine, University of Padova, Padova, Italy.
- Department of Clinical and Experimental Medicine, Unit of Medicine and Hepatology, University of Messina, Messina, Italy.
- Institute of Hepatology Foundation for Liver Research London UK, School of Immunology and Microbial Sciences King's College London, London, UK.
Zitieren
APA
Romano, A., Zeni, N., Caspanello, A. R., Phillips, S., Piano, S. S., & Angeli, P. (2024). Follow‐up post‐ HCV virological response to DAA in advanced chronic liver disease. Liver International. https://doi.org/10.1111/liv.16113
Vancouver
Romano A, Zeni N, Caspanello AR, Phillips S, Piano SS, Angeli P. Follow‐up post‐ HCV virological response to DAA in advanced chronic liver disease. Liver International. 2024. doi:10.1111/liv.16113
BibTeX
@article{Romano2024,
author = {Romano, A and Zeni, N and Caspanello, A R and Phillips, S and Piano, S S and Angeli, P},
title = {Follow‐up post‐ HCV virological response to DAA in advanced chronic liver disease},
journal = {Liver International},
year = {2024},
doi = {10.1111/liv.16113}
}
EUVIMED